GeminIQ Website Logo

Viewing CRON free

Subscribe for full history, 90+ metrics, screener, watchlist...

Cronos Group Inc.

CRON

Companies in Medicinal Chemicals & Botanical Products

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
467822792784794798859862848855669572
Short Term Investments
3300404040400000192268
Accounts Receivable Net Current
373334272719152016151416
Interest Receivable Current
46973597541012
Assets Current
Assets Current
912928944922927919936959935942933918
Other Receivables Net Current
214144107567665
Notes And Loans Receivable Net Current
-00001105665
Inventory Net
534947484235334729313036
Prepaid Expense And Other Assets Current
558956675656
Assets Held For Sale Not Part Of Disposal Group Cu…
--03688919190-
Other Long Term Investments
5581123333203562
Equity Method Investments
------0021211918
Notes And Loans Receivable Net Noncurrent
172121221416161673676968
Property Plant And Equipment Net
14214214614615013913316337375956
Operating Lease Right Of Use Asset
111221111111
Goodwill
64656665676363381111
Intangible Assets Net Excluding Goodwill
89910111111419202124
Other Assets Noncurrent
-------0000-
Deferred Income Tax Assets Net
1120333---01
Assets
1,1801,1721,1971,1781,1751,1541,1661,1841,0911,1091,1401,150
Liabilities
Accounts Payable Current
1710121112917789125
Accrued Income Taxes Current
410000000001
Liabilities Current
Accrued Liabilities Current
353136302523323224232824
Liabilities Current
564248413833504033334131
Operating Lease Liability Current
000111111111
Derivative Liabilities Current
--0000000000
Other Liabilities Current
------000000
Other Liabilities Noncurrent
011111111111
Operating Lease Liability Noncurrent
111111111122
Deferred Income Tax Liabilities Net
544365411--0-
Liabilities
624854464539555335364433
Stockholders Equity Inclu…
Common Stock Value
632647663666667669670616616616662613
Additional Paid In Capital
-------5249484847
Retained Earnings Accumulated Deficit
492461448450424464458414406414417462
Accumulated Other Comprehensive Income Loss Net Of…
-56-34-17-34-8-66-64-0-12-221-2
Stockholders Equity
1,1171,1241,1431,0831,0821,1151,1111,0821,0591,0761,0961,120
Minority Interest
4950495048484750-4-4-3-3
Liabilities And Stockholders Equity
1,1801,1721,1971,1781,1751,1541,1661,1841,0911,1091,1401,150
Allowance For Notes And Loans Receivable Current
---0--------
Allowance For Notes And Loans Receivable Noncurren…
---5--------
Common Stock Shares Issued
371376382383384385383382382382381381
Shares Outstanding
371376382383384385383382382382381381

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-0.36%4.00%2.91%---------
2025-1.00%-5.00%2.50%14.54%15.86%11.01%0.00%7.69%12.55%-10.49%0.75%-1.50%
2024-9.12%-18.25%-15.09%-2.59%-6.47%-4.31%-9.73%-8.41%-15.93%-10.50%-11.50%7.00%
2023---12.57%14.29%-1.71%5.00%4.50%-2.00%25.48%13.94%39.42%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
16.18
21.87
19.59
22.45
24.65
27.80
18.84
24.24
28.29
28.19
22.54
30.03
Quick Ratio
15.15
20.61
18.45
21.07
23.39
26.56
18.04
22.86
27.25
27.09
21.68
28.67
Working Capital
855.67M
885.46M
895.90M
881.08M
889.54M
885.53M
886.41M
919.61M
902.22M
908.80M
891.91M
887.80M
Leverage & Debt
Debt to Equity
0.06
0.04
0.05
0.04
0.04
0.04
0.05
0.05
0.03
0.03
0.04
0.03
Interest Coverage TTM
-0.06
-0.39
-0.44
-0.50
-1.27
-1.36
-1.47
-1.60
-1.36
-1.47
-1.66
-1.85
Debt Ratio
0.05
0.04
0.05
0.04
0.04
0.03
0.05
0.04
0.03
0.03
0.04
0.03
Efficiency & Turnover
Asset Turnover TTM
0.20
0.18
0.16
0.15
0.15
0.15
0.14
0.13
0.13
0.11
0.10
0.09
Days Sales Outstanding TTM
48.82
44.82
46.78
49.28
44.91
36.91
33.21
42.73
36.92
42.68
56.29
56.24
Receivables Turnover TTM
7.48
8.14
7.80
7.41
8.13
9.89
10.99
8.54
9.89
8.55
6.48
6.49
Per Share Metrics
Diluted EPS TTM
0.19
0.00
-0.02
0.09
0.05
0.13
0.11
-0.12
-0.15
-0.15
-0.19
-0.28
Free Cash Flow Per Share TTM
0.06
0.01
-0.06
-0.03
-0.04
-0.02
0.02
0.05
0.03
-0.00
-0.12
-0.23
Dividend Per Share TTM
0.03
0.04
0.04
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
34.68%
32.40%
32.46%
32.57%
24.53%
20.46%
15.57%
10.54%
11.74%
10.43%
9.90%
9.77%
Operating Profit Margin TTM
-1.03%
-7.20%
-9.00%
-12.07%
-31.29%
-38.40%
-47.29%
-56.13%
-52.77%
-61.96%
-70.51%
-76.03%
Net Profit Margin TTM
30.38%
0.07%
-4.89%
20.49%
10.63%
29.37%
25.39%
-30.68%
-40.46%
-44.18%
-61.50%
-95.62%
Growth Metrics
Net Revenue Growth (1Y)
36.14%
24.99%
19.49%
13.91%
22.52%
30.42%
34.55%
36.86%
35.01%
21.26%
10.04%
-0.85%
Net Income Growth (1Y)
289.09%
-99.71%
-123.00%
-176.09%
-132.19%
-186.69%
-155.54%
-56.09%
-59.92%
-63.27%
-56.17%
-51.66%
EPS Growth (1Y)
301.27%
-99.71%
-122.91%
-175.93%
-131.93%
-186.35%
-155.38%
-56.23%
-60.04%
-63.34%
-56.63%
-52.04%
Valuation Metrics
P/E TTM
14.44
6,705.84
-106.76
29.50
39.80
14.02
18.79
-17.65
-15.50
-17.46
-10.77
-7.05
P/B TTM
0.93
0.85
0.88
0.94
0.65
0.62
0.69
0.74
0.84
0.93
0.73
0.68
P/S TTM
4.39
4.53
5.22
6.05
4.23
4.12
4.77
5.41
6.27
7.71
6.62
6.75
Market Cap
1.04B
952.23M
1.01B
1.06B
735.93M
693.16M
771.76M
837.21M
890.43M
995.57M
796.22M
762.20M
Enterprise Value
571.61M
130.37M
216.73M
280.81M
-58.48M
-104.66M
-87.05M
-24.83M
42.24M
140.45M
126.93M
190.54M
Calculated Values
Free Cash Flow TTM
23.17M
3.68M
-22.69M
-10.86M
-14.52M
-6.99M
6.43M
17.85M
12.49M
-793.00K
-45.36M
-87.20M
Net Debt
-467.02M
-821.86M
-791.79M
-784.17M
-794.42M
-797.82M
-858.81M
-862.03M
-848.19M
-855.11M
-669.29M
-571.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2023-05-30Purchase
Owner: Adler, Jason Marc
Title: -
Shares: 37,500
Price/Share: $1.74
Value: $65,250.00
Shares Owned: 1,402,304
Relationship: Director
Ownership: Indirect
2023-05-25Purchase
Owner: Adler, Jason Marc
Title: -
Shares: 100,000
Price/Share: $1.80
Value: $180,000.00
Shares Owned: 1,376,054
Relationship: Director
Ownership: Indirect
2023-05-23Purchase
Owner: Adler, Jason Marc
Title: -
Shares: 100,000
Price/Share: $1.90
Value: $190,000.00
Shares Owned: 1,306,055
Relationship: Director
Ownership: Indirect
2023-05-19Purchase
Owner: Adler, Jason Marc
Title: -
Shares: 100,000
Price/Share: $1.89
Value: $189,000.00
Shares Owned: 1,236,056
Relationship: Director
Ownership: Indirect
2023-05-18Purchase
Owner: Adler, Jason Marc
Title: -
Shares: 11,420
Price/Share: $1.80
Value: $20,556.00
Shares Owned: 1,166,056
Relationship: Director
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
12.71%
Inst. Shares: 48,216,773
Shares Outstanding: 379,374,109
2025-12-31
13.39%
Inst. Shares: 51,350,216
Shares Outstanding: 383,468,522
2025-09-30
12.96%
Inst. Shares: 49,643,856
Shares Outstanding: 383,086,739
2025-06-30
12.24%
Inst. Shares: 47,165,850
Shares Outstanding: 385,306,213
2025-03-31
11.43%
Inst. Shares: 43,780,509
Shares Outstanding: 382,958,797

Cronos Group Inc. (CRON) — SEC Financial Statements & Analysis

Cronos Group Inc. (CRON) is a medicinal chemicals & botanical products company, incorporated in A1. Cronos Group Inc. trades on Nasdaq as: CRON. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cronos Group Inc. reported a 36.14% year-over-year revenue growth, a Gross Profit Margin of 34.68% (TTM), a Debt-to-Equity ratio of 0.06x, a Price-to-Sales (P/S) ratio of 4.39x (TTM), a Price-to-Book (P/B) ratio of 0.93 (TTM), at a market cap of $1.04B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
36.14%
Gross Profit Margin TTM
34.68%
Debt To Equity
0.06x
P/S TTM
4.39x
P/B TTM
0.93
Market Cap
$1.04B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cronos Group Inc. in?

Cronos Group Inc. (CRON) operates in the Medicinal Chemicals & Botanical Products industry.

What is CRON's market cap?

Cronos Group Inc. (CRON) has a market capitalization of $1.04B as of 2026-06-30.

What is CRON's P/E ratio?

Cronos Group Inc. (CRON)'s trailing twelve month P/E ratio is 14.44x as of 2026-06-30.

What exchange does CRON trade on?

Cronos Group Inc. (CRON) trades on the Nasdaq.

Where is Cronos Group Inc. incorporated?

Cronos Group Inc. is incorporated in British Columbia, Canada.

Research Faster.
Invest Smarter.

Cronos Group Inc. (CRON) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.